David Harris
Psychiatry · Detroit, MINPI 1497799951
Payments from drug & device makers
Across 595 payments — averaging $18.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$2K
- Johnson & Johnson$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- AbbVie$1K
- Neurocrine Biosciences, Inc.$765
- Teva Pharmaceuticals USA, Inc.$750
- plus $4K from 21 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 84 | $1,509 |
| Johnson & Johnson | 43 | $1,352 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 88 | $1,337 |
| AbbVie(2 entities) | 51 | $1,026 |
| Neurocrine Biosciences, Inc. | 30 | $765 |
| Teva Pharmaceuticals USA, Inc. | 36 | $750 |
| Alkermes, Inc. | 34 | $706 |
| Corium, LLC | 41 | $602 |
| Axsome Therapeutics, Inc. | 14 | $371 |
| Ironshore Pharmaceuticals Inc. | 17 | $316 |
| Sunovion Pharmaceuticals Inc. | 49 | $314 |
| E.r. Squibb & Sons, L.L.C. | 14 | $298 |
| Almatica Pharma LLC | 15 | $285 |
| Lundbeck LLC | 17 | $212 |
| Indivior Inc. | 9 | $207 |
| Vanda Pharmaceuticals Inc. | 8 | $167 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $142 |
| Neos Therapeutics, LP | 13 | $129 |
| Luye Pharma (USA) Ltd. | 6 | $102 |
| Collegium Pharmaceutical, Inc. | 5 | $100 |
| Noven Therapeutics, LLC | 3 | $52 |
| Tempus AI, Inc | 2 | $37 |
| Supernus Pharmaceuticals, Inc. | 2 | $32 |
| Shire North American Group Inc | 2 | $27 |
| Neuronetics, Inc. | 1 | $18 |
| Vertical Pharmaceuticals, LLC | 1 | $12 |
| Acadia Pharmaceuticals Inc | 1 | $11 |
How this compares
$10,876 in reported general payments places this provider in the 95th percentile of 1,166 psychiatry providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Detroit
- Andreas SidiropoulasDetroit$2.8M
- Arash JavanbakhtDetroit$102K
- Matcheri KeshavanDetroit$48K
- Gerald WinderDetroit$30K
- John HeadDetroit$28K
- Joel YoungRochester Hills$1.9M
- Welton WashingtonYpsilanti$1.4M
- Rajaprabhakaran RajarethinamAnn Arbor$1.2M
- Eric AchtyesGrand Rapids$705K
- Manzar RajputMonroe$612K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.